Yun Qiu Selected Research

Complement Factor D (Factor D)

1/2022	Inverse Association of Serum Adipsin with the Remission of Nonalcoholic Fatty-Liver Disease: A 3-Year Community-Based Cohort Study.
6/2021	Anthocyanins regulate serum adipsin and visfatin in patients with prediabetes or newly diagnosed diabetes: a randomized controlled trial.
1/2019	Association of Circulating Adipsin, Visfatin, and Adiponectin with Nonalcoholic Fatty Liver Disease in Adults: A Case-Control Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yun Qiu Research Topics

Disease

25	Prostatic Neoplasms (Prostate Cancer) 04/2022 - 09/2002
25	Neoplasms (Cancer) 04/2022 - 11/2004
24	Crohn Disease (Crohn's Disease) 01/2022 - 02/2015
9	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 01/2017
7	Inflammation (Inflammations) 01/2022 - 10/2017
7	Infections 01/2022 - 01/2020
5	Hypoxia (Hypoxemia) 06/2022 - 08/2005
5	Colitis 09/2021 - 11/2016
5	COVID-19 03/2021 - 01/2020
4	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2018
4	Fibrosis (Cirrhosis) 07/2021 - 08/2005
4	Hypertension (High Blood Pressure) 01/2020 - 10/2019
3	Obesity 05/2022 - 01/2019
3	Ulcerative Colitis 01/2022 - 10/2019
3	Reperfusion Injury 01/2021 - 01/2018
3	Ischemia 01/2019 - 07/2017
3	Carcinogenesis 12/2018 - 09/2010
2	Myocardial Ischemia (Ischemic Heart Diseases) 06/2022 - 01/2018
2	Infarction (Infarctions) 06/2022 - 01/2018
2	Abdominal Obesity 05/2022 - 01/2019
2	Glioblastoma (Glioblastoma Multiforme) 02/2022 - 10/2019
2	Necrosis 01/2022 - 01/2021
2	Insulin Resistance 01/2022 - 01/2020
2	Pathologic Constriction (Stenosis) 07/2021 - 06/2020
2	Prediabetic State (Prediabetes) 06/2021 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 06/2021 - 01/2020
2	Communicable Diseases (Infectious Diseases) 01/2021 - 01/2020
2	Vascular Remodeling 01/2020 - 10/2019
2	Breast Neoplasms (Breast Cancer) 08/2010 - 08/2006
1	Hyperglycemia 06/2022
1	Disease Progression 01/2022
1	Parkinson Disease (Parkinson's Disease) 01/2022
1	Neuroinflammatory Diseases 01/2022

Drug/Important Bio-Agent (IBA)

14	Pharmaceutical PreparationsIBA 07/2021 - 08/2006
13	AndrogensIBA 01/2017 - 09/2002
10	Androgen Receptors (Androgen Receptor)IBA 10/2016 - 03/2004
9	Proteins (Proteins, Gene)FDA Link 04/2022 - 11/2004
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2011
5	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 01/2017
5	C-Reactive ProteinIBA 01/2021 - 06/2017
5	Small Interfering RNA (siRNA)IBA 03/2011 - 11/2004
5	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2011 - 03/2004
4	Tyrosine (L-Tyrosine)FDA Link 04/2022 - 10/2006
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 09/2017
4	Sirtuin 1IBA 01/2022 - 01/2018
4	Infliximab (Remicade)FDA Link 03/2021 - 10/2017
4	Biological ProductsIBA 01/2020 - 04/2005
4	Hormones (Hormone)IBA 01/2011 - 10/2006
4	Phosphotransferases (Kinase)IBA 10/2006 - 09/2002
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 06/2022 - 01/2009
3	Docetaxel (Taxotere)FDA Link 04/2022 - 02/2008
3	Complement Factor D (Factor D)IBA 01/2022 - 01/2019
3	AdipokinesIBA 01/2022 - 09/2018
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2020 - 10/2006
3	AntibodiesIBA 06/2020 - 06/2015
3	Thalidomide (Thalomid)FDA Link 02/2020 - 05/2017
3	Messenger RNA (mRNA)IBA 01/2020 - 08/2005
3	MicroRNAs (MicroRNA)IBA 12/2018 - 01/2017
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2013 - 07/2010
3	Proto-Oncogene Proteins c-pim-1 (Proto Oncogene Proteins c pim 1)IBA 01/2013 - 02/2008
2	src-Family KinasesIBA 04/2022 - 10/2006
2	Anthocyanins (Anthocyanin)IBA 06/2021 - 01/2020
2	Nicotinamide PhosphoribosyltransferaseIBA 06/2021 - 01/2019
2	GYY 4137IBA 01/2021 - 01/2018
2	Therapeutic UsesIBA 01/2020 - 10/2019
2	Azathioprine (Imuran)FDA LinkGeneric 01/2020 - 03/2018
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2020
2	Angiotensin IIIBA 01/2020 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 11/2019
2	Immunologic Factors (Immunomodulators)IBA 01/2020 - 09/2017
2	AdiponectinIBA 01/2020 - 01/2019
2	Triglycerides (Triacylglycerol)IBA 01/2020 - 01/2019
2	enzalutamideIBA 01/2020 - 10/2019
2	Circular RNAIBA 10/2019 - 12/2018
2	nicotinamide-beta-ribosideIBA 05/2019 - 01/2018
2	Interleukin-9 (Interleukin 9)IBA 01/2018 - 10/2017
2	CytokinesIBA 01/2018 - 03/2004
2	LigandsIBA 01/2017 - 03/2004
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 08/2010 - 02/2008
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 08/2010 - 02/2008
2	Interleukin-6 (Interleukin 6)IBA 07/2010 - 03/2004
1	MB Form Creatine KinaseIBA 06/2022
1	Leucine-Rich Repeat ProteinsIBA 06/2022
1	oxidized low density lipoproteinIBA 05/2022
1	taxaneIBA 04/2022
1	cabazitaxel FDA Link 04/2022
1	TubulinIBA 04/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 04/2022
1	Transcription Factor 4IBA 02/2022
1	Transcription Factors (Transcription Factor)IBA 02/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	PPAR gammaIBA 01/2022
1	Fatty Acid-Binding ProteinsIBA 01/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Coffee FDA Link 01/2022
1	LipopolysaccharidesIBA 01/2022

Therapy/Procedure

30	Therapeutics 01/2022 - 03/2006
8	Castration 01/2020 - 04/2005
1	Ischemic Postconditioning 06/2022
1	Tonsillectomy 01/2022